Regulatory affairs

(ChakisAtelier/iStock via Getty Images Plus)

Latest COVID-19 news from the FDA

By Jenni Spinner

The US agency continues to issue advice for life-sciences professionals engaged in work related to the virus, and keep an eye out for fraudulent products.

(ClaudioVentrella/iStock via Getty Images Plus)

Breaking FDA COVID-19 news

By Jenni Spinner

The agency continues to take actions and issue advice related to COVID-19 treatments, tests, consumer products and other pressing industry concerns.

Current FDA COVID-19 news

Current FDA COVID-19 news

By Jenni Spinner

The US federal agency continues to keep busy offering resources, issuing EUAs and taking action related to the COVID-19 pandemic.

(Frantab/iStock via Getty Images Plus)

PRA: get ready for the RACE Act

By Jenni Spinner

Experts from the CRO offers insight on preparing for the changes to the pediatric oncology research requirements, which take effect next week.

(Isabela Maia Studio/iStock via Getty Images Plus)

This week's FDA COVID-19 news

By Jenni Spinner

The agency continues to provide resources for the life-sciences industry, approve tests, and take action against companies offering false treatments

(wildpixel/iStock via Getty Images Plus)

Most recent FDA COVID-19 updates

By Jenni Spinner

The US agency continues to put out informational resources, issue EUAs for tests and treatments, and monitor industry activity related to the virus.

(Image: Eastman Kodak)

Kodak Pharmaceuticals lands $765m US loan

By Jenni Spinner

The imaging company’s newly launched division, created to produce drug ingredients, received the loan from the US International Development Finance Corp.

(bennymarty/iStock via Getty Images Plus)

This week’s FDA COVID-19 updates

By Jenni Spinner

The US agency continues releasing resources, offering advice and taking actions related to the pandemic, and how life-sciences professionals respond.

Follow us

Product Innovations